Loading data for BNTC — first visit, this takes a few seconds.

알림

Benitec Biopharma Inc. (BNTC)

NasdaqCM: BNTC · 실시간 가격 · USD

12.54

+0.20 (1.62%)

종가 기준: Aug 18, 2026, 8:00 PM

1.62% (1D)

데이터 없음

매수호가	8.9
시가총액	442.48M
매출 (ttm)	n/a
순이익 (ttm)	-41.54M
베타	0.26
EPS (ttm)	-0.93
P/E (ttm)	n/a
선행 P/E	-1.37
P/B (ttm)	2.41
P/S (ttm)	n/a
Earnings Date	Sep 22, 2026

매도호가	16.01
거래량	6,000
평균 거래량 (20일)	124,382
시가	12.40
전일 종가	12.34
일중 범위	12.40 - 12.77
52주 범위	9.85 - 16.76
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

BNTC 소개

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The com...

[더 보기]

산업 Biotechnology

섹터 Healthcare

IPO 일자 Jun 24, 2014

직원 수 19

상장 거래소 NasdaqCM

티커 BNTC

웹사이트 https://benitec.com

전체 기업 정보

재무 실적

2025년 Benitec Biopharma의 매출은 0로, 전년 0 대비 undefined% 증가했습니다. 순이익은 -37.92M로, 74.32% 증가했습니다.

재무제표

어닝 서프라이즈

Benitec Biopharma가 May 14, 2026에 분기 실적을 발표했습니다:

매출 $0 예상치 하회 $0, 및 NaN% 전년 대비 성장.

EPS -0.24 예상치 상회 0.04, 및 0.00% 전년 대비 성장.

다음 실적 발표

Benitec Biopharma Inc.의 실적 발표 예정일은 Sep 22, 2026, 장 시작 전입니다.
애널리스트 예상 매출은 ... 업그레이드

뉴스

6개월 전 · Simply Wall St.

Here's Why We're Not At All Concerned With Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Situation

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

7개월 전 · Zacks

Does Benitec Biopharma (BNTC) Have the Potential to Rally 83.87% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 83.9% in Benitec Biopharma (BNTC). While the effectiveness of this highly sought-after metric is questionable, ...

8개월 전 · Zacks

Wall Street Analysts Predict an 87.48% Upside in Benitec Biopharma (BNTC): Here's What You Should Know

The mean of analysts' price targets for Benitec Biopharma (BNTC) points to an 87.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement amo...

8개월 전 · Zacks

Down 25.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Benitec Biopharma (BNTC)

Benitec Biopharma (BNTC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in ...

9개월 전 · Insider Monkey

Citizens Lifts Benitec Biopharma Inc. (BNTC) Price Target on Topline Results for Oculopharyngeal Muscular Dystrophy Treatment

Benitec Biopharma Inc. (NASDAQ:BNTC) is one of the best breakout stocks to invest in. On November 4, an analyst at Citizens JMP raised the stock’s price target to $22 from $20 while reiterating an Out...

2 페이지 중 1

Benitec Biopharma Inc. (BNTC)